NRIX
Nurix Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.14
+3.24%0
Insider buys (3m)
15
Insider sells (3m)
-$2.1M
Net value (3m)
+74.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 5,787 | $8.72 |
| Sep 2, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 400 | $27 |
| Sep 2, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 5,387 | $26 |
| Sep 1, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | M-Exempt | 1,452 | $1.86 |
| Sep 1, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | Sale | 1,452 | $25 |
| Aug 5, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | Sale | 4,356 | $25 |
| Aug 5, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | Sale | 2,611 | $25 |
| Aug 5, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | M-Exempt | 4,356 | $1.86 |
| Aug 5, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | Sale | 1,500 | $24 |
| Aug 4, 2026 | van Houte Hans · officer: Chief Financial Officer | Sale | 1,794 | $24 |
| Aug 4, 2026 | van Houte Hans · officer: Chief Financial Officer | Sale | 2,967 | $25 |
| Aug 3, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 16,589 | $23 |
| Aug 3, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 5,787 | $8.72 |
| Jul 30, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 3,750 | $0.00 |
| Jul 30, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | Sale | 3,847 | $23 |
| Jul 30, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | M-Exempt | 3,750 | $0.00 |
| Jul 30, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 3,847 | $23 |
| Jul 30, 2026 | van Houte Hans · officer: Chief Financial Officer | Sale | 2,845 | $23 |
| Jul 30, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 2,858 | $0.00 |
| Jul 30, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | M-Exempt | 2,858 | $0.00 |
| Jul 30, 2026 | van Houte Hans · officer: Chief Financial Officer | M-Exempt | 3,750 | $0.00 |
| Jul 30, 2026 | van Houte Hans · officer: Chief Financial Officer | M-Exempt | 2,858 | $0.00 |
| Jul 30, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 3,572 | $0.00 |
| Jul 30, 2026 | Hansen Gwenn · officer: Chief Scientific Officer | M-Exempt | 3,572 | $0.00 |
| Jul 30, 2026 | van Houte Hans · officer: Chief Financial Officer | M-Exempt | 3,572 | $0.00 |
| Jul 2, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 5,221 | $1.86 |
| Jul 2, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 11,008 | $24 |
| Jul 2, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 5,787 | $8.72 |
| Jun 25, 2026 | Ring Christine · officer: Chief Legal Officer | Sale | 28,935 | $20 |
| Jun 25, 2026 | Ring Christine · officer: Chief Legal Officer | M-Exempt | 15,602 | $8.72 |
Institutional positioning
13F filings over the trailing two quarters
New 92Increased 133Reduced 110Sold out 30
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 8,925,642 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 8,770,349 | Aug 7, 2026 |
| Vestal Point Capital, LP | Increased | 8,050,000 | Aug 14, 2026 |
| Deep Track Capital, LP | Increased | 7,736,455 | Aug 14, 2026 |
| REDMILE GROUP, LLC | Reduced | 7,732,808 | May 15, 2026 |
| Rubric Capital Management LP | Increased | 7,227,778 | Aug 14, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 6,500,000 | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 6,345,244 | May 15, 2026 |
| FMR LLC | Increased | 5,541,271 | May 15, 2026 |
| FMR LLC | Reduced | 5,485,215 | Aug 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5,436,587 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 5,141,195 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 4,931,999 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 4,762,484 | Aug 13, 2026 |
| STATE STREET CORP | Reduced | 4,677,244 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026